BIZTRAC BETA
Wholesale of pharmaceutical and medical goods

CLINISCIENCES AS

Org. no. 933500691 Limited company (AS) Oslo Incorporated 2024 Active
Ownership graph ↗
Revenue 2025 NOK 191,000
Operating profit NOK 9,000
Equity NOK 107,000
Incorporated 2024
Share capital NOK 100,000

CLINISCIENCES AS is registered as a limited company in Oslo, Oslo with organisation number 933500691. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 2024. Registered share capital is NOK 100,000, divided into 1000 shares. The company's stated purpose is: “Enten selv eller gjennom hel- eller deleide selskaper eller ved samarbeid med andre selskaper handel med laboratorie reagenser og utstyr for diagnostisering eller forskningsformål, samt annen virksomhet som anses forenlig hermed.”. The most recent filed accounts, for the 2025 financial year, show NOK 191,000 in revenue and NOK 9,000 in operating profit.

Key figures · 2025

Revenue
NOK 191,000
Operating profit
NOK 9,000
Equity
NOK 107,000
Est. value
NOK 88,000

Financial health · 2024

Liquidity
1.52
Good
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
34.3%
Good
Equity as a share of total capital

Who owns CLINISCIENCES AS?

CLINI HOLDING EURL
CLINISCIENCES AS
NOK 191,000 rev. · NOK 9,000 profit

CLINISCIENCES AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about CLINISCIENCES AS

Who owns CLINISCIENCES AS?

CLINI HOLDING EURL is the largest registered owner, with 100.0%.

What is the revenue of CLINISCIENCES AS?

CLINISCIENCES AS had revenue of NOK 191,000 in 2025.

Who is the general manager of CLINISCIENCES AS?

Rushentan Alexandre Rasiah is registered as general manager of CLINISCIENCES AS.

Where is CLINISCIENCES AS based?

CLINISCIENCES AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.